Annual EBITDA
-$1.50 M
+$4.85 M+76.42%
September 30, 2024
Summary
- As of March 10, 2025, YCBD annual EBITDA is -$1.50 million, with the most recent change of +$4.85 million (+76.42%) on September 30, 2024.
- During the last 3 years, YCBD annual EBITDA has risen by +$20.51 million (+93.21%).
- YCBD annual EBITDA is now -358.83% below its all-time high of $577.60 thousand, reached on September 30, 2018.
Performance
YCBD EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
$252.90 K
-$235.20 K-48.19%
December 31, 2024
Summary
- As of March 10, 2025, YCBD quarterly EBITDA is $252.90 thousand, with the most recent change of -$235.20 thousand (-48.19%) on December 31, 2024.
- Over the past year, YCBD quarterly EBITDA has stayed the same.
- YCBD quarterly EBITDA is now -99.35% below its all-time high of $38.87 million, reached on September 30, 2022.
Performance
YCBD Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$608.40 K
+$674.80 K+52.59%
December 31, 2024
Summary
- As of March 10, 2025, YCBD TTM EBITDA is -$608.40 thousand, with the most recent change of +$674.80 thousand (+52.59%) on December 31, 2024.
- Over the past year, YCBD TTM EBITDA has stayed the same.
- YCBD TTM EBITDA is now -101.81% below its all-time high of $33.69 million, reached on June 30, 2023.
Performance
YCBD TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
YCBD EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +76.4% | 0.0% | 0.0% |
| 3 y3 years | +93.2% | +132.5% | -116.1% |
| 5 y5 years | +89.4% | +132.5% | -116.1% |
YCBD EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +93.2% | -99.3% | +100.8% | -101.8% | +98.9% |
| 5 y | 5-year | at high | +93.2% | -99.3% | +100.8% | -101.8% | +98.9% |
| alltime | all time | -358.8% | +93.2% | -99.3% | +100.8% | -101.8% | +98.9% |
CbdMD EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | - | $252.90 K(-48.2%) | -$608.40 K(-52.6%) |
| Sep 2024 | -$1.50 M(-76.4%) | $488.10 K(-53.9%) | -$1.28 M(-57.6%) |
| Jun 2024 | - | $1.06 M(-144.0%) | -$3.03 M(-40.6%) |
| Mar 2024 | - | -$2.41 M(+470.6%) | -$5.09 M(+47.1%) |
| Dec 2023 | - | -$421.90 K(-66.4%) | -$3.46 M(-46.2%) |
| Sep 2023 | -$6.34 M(-55.8%) | -$1.26 M(+24.7%) | -$6.43 M(-119.1%) |
| Jun 2023 | - | -$1.01 M(+29.6%) | $33.69 M(+790.2%) |
| Mar 2023 | - | -$777.50 K(-77.1%) | $3.78 M(+392.9%) |
| Dec 2022 | - | -$3.39 M(-108.7%) | $767.80 K(-105.4%) |
| Sep 2022 | -$14.34 M(-34.8%) | $38.87 M(-225.7%) | -$14.34 M(-74.3%) |
| Jun 2022 | - | -$30.91 M(+714.7%) | -$55.74 M(+146.3%) |
| Mar 2022 | - | -$3.79 M(-79.5%) | -$22.63 M(-27.8%) |
| Dec 2021 | - | -$18.50 M(+628.7%) | -$31.33 M(+42.3%) |
| Sep 2021 | -$22.01 M(+40.3%) | -$2.54 M(-215.4%) | -$22.01 M(-6.3%) |
| Jun 2021 | - | $2.20 M(-117.6%) | -$23.48 M(-9.4%) |
| Mar 2021 | - | -$12.49 M(+36.0%) | -$25.92 M(+37.4%) |
| Dec 2020 | - | -$9.18 M(+129.0%) | -$18.86 M(+20.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | -$15.68 M(+11.4%) | -$4.01 M(+1525.5%) | -$15.68 M(-4.6%) |
| Jun 2020 | - | -$246.60 K(-95.5%) | -$16.43 M(-27.1%) |
| Mar 2020 | - | -$5.43 M(-9.5%) | -$22.55 M(+18.4%) |
| Dec 2019 | - | -$6.00 M(+26.1%) | -$19.04 M(+35.3%) |
| Sep 2019 | -$14.07 M(-2536.1%) | -$4.76 M(-25.3%) | -$14.07 M(+41.8%) |
| Jun 2019 | - | -$6.37 M(+231.4%) | -$9.93 M(+244.7%) |
| Mar 2019 | - | -$1.92 M(+87.0%) | -$2.88 M(-500.1%) |
| Dec 2018 | - | -$1.03 M(+68.0%) | $719.60 K(+41.0%) |
| Sep 2018 | $577.60 K(-173.2%) | -$611.60 K(-189.9%) | $510.30 K(-41.7%) |
| Jun 2018 | - | $680.30 K(-59.5%) | $875.50 K(+236.2%) |
| Mar 2018 | - | $1.68 M(-235.7%) | $260.40 K(-117.7%) |
| Dec 2017 | - | -$1.24 M(+401.8%) | -$1.47 M(+86.5%) |
| Sep 2017 | -$789.30 K(-78.6%) | -$246.40 K(-477.9%) | -$789.30 K(-49.4%) |
| Jun 2017 | - | $65.20 K(-220.5%) | -$1.56 M(-48.8%) |
| Mar 2017 | - | -$54.10 K(-90.2%) | -$3.05 M(+1.8%) |
| Dec 2016 | - | -$554.00 K(-45.5%) | -$2.99 M(+22.7%) |
| Sep 2016 | -$3.69 M | -$1.02 M(-28.5%) | -$2.44 M(+71.5%) |
| Jun 2016 | - | -$1.42 M | -$1.42 M |
FAQ
- What is cbdMD annual EBITDA?
- What is the all time high annual EBITDA for cbdMD?
- What is cbdMD annual EBITDA year-on-year change?
- What is cbdMD quarterly EBITDA?
- What is the all time high quarterly EBITDA for cbdMD?
- What is cbdMD quarterly EBITDA year-on-year change?
- What is cbdMD TTM EBITDA?
- What is the all time high TTM EBITDA for cbdMD?
- What is cbdMD TTM EBITDA year-on-year change?
What is cbdMD annual EBITDA?
The current annual EBITDA of YCBD is -$1.50 M
What is the all time high annual EBITDA for cbdMD?
cbdMD all-time high annual EBITDA is $577.60 K
What is cbdMD annual EBITDA year-on-year change?
Over the past year, YCBD annual EBITDA has changed by +$4.85 M (+76.42%)
What is cbdMD quarterly EBITDA?
The current quarterly EBITDA of YCBD is $252.90 K
What is the all time high quarterly EBITDA for cbdMD?
cbdMD all-time high quarterly EBITDA is $38.87 M
What is cbdMD quarterly EBITDA year-on-year change?
Over the past year, YCBD quarterly EBITDA has changed by $0.00 (0.00%)
What is cbdMD TTM EBITDA?
The current TTM EBITDA of YCBD is -$608.40 K
What is the all time high TTM EBITDA for cbdMD?
cbdMD all-time high TTM EBITDA is $33.69 M
What is cbdMD TTM EBITDA year-on-year change?
Over the past year, YCBD TTM EBITDA has changed by $0.00 (0.00%)